Pacific Bridge Medical, Jan 2011, Pages: 203
of SFDA-affiliated organizations in China
- Healthcare statistics and pharmaceutical markets in Asia (charts) ChinaPharmaceuticalRegulatoryReport 2011 + Appendix
GBI Research, Dec 2011, Pages: 76
, India and China) is also detailed in the report. Key cost and developmental issues are also addressed. The report provides analysis on the competitive landscape, including the benchmarking of top
GBI Research, Sep 2011, Pages: 85
pharmaceutical sector. 1.1 List of Tables
1.2 List of Figures
2 Emerging Pharmaceutical Market: China – Introduction
2.1 GBI Research Report Guidance
3 Emerging Pharmaceutical Market: China – Macroeconomic
Business Insights, Dec 2010, Pages: 215
of action of botanical drugs.
While China in particular can boast the successful innovation of novel drugs (gene therapies) ahead of companies in the West, it is notable that regulatory approvals
Pacific Bridge Medical, Jan 2011, Pages: 92
Drug Industry Appendix B: National Reimbursement Drug List (2009), The National Essential Drug List (2009) Appendix C: Key Drug Agencies in ChinaChinaPharmaceutical Market Report 2011
Pacific Bridge Medical, Jan 2011, Pages: 74
This regulatoryreport includes an overview of the pharmaceutical and healthcare industry in China, as well as a discussion of all the relevant Chinese laws and regulations that govern the testing
GBI Research, Dec 2009, Pages: 62
, key trends analysis on mergers and acquisitions, and licensing agreements involving pharmaceutical packaging is detailed.
This report is built using data and information sourced from proprietary
Taiyou Research, Nov 2011, Pages: 240
as well.
In this industry scenario, Taiyou Research analyzes the Pharmaceutical Industry in China. The report covers the following:
- Overview of the Chinese pharmaceutical industry containing an industry
Business Insights, Jan 2011, Pages: 96
This report discusses market dynamics, drivers, resistors and future outlook of CMO industry in China. It also includes manufacturing capabilities, growth strategies, SWOT analysis of the top 10
GBI Research, Aug 2011, Pages: 108
and challenges in the Indian pharmaceutical industry. The report analyzes effective strategies adopted by industry participants that shape industry dynamics. Further, the report provides competitive benchmarking
Access Asia Ltd., Aug 2006, Pages: 307
the market for over-the-counter (OTC) pharmaceuticals in the People’s Republic of China. The report covers the following sectors:
- Analgesics
- Cough, cold and allergy (hay-fever) remedies
- Digestive remedies
GBI Research, June 2011, Pages: 95
- Counterfeiting Poses Threats to Patient Safety and Revenues of Pharmaceutical Companies”, provides in-depth analysis of trends, issues and challenges in this industry. The report analyzes the effects
JZMed Inc., May 2011, Pages: 230
of those countries that are interested in learning the current and future development of the Chinese pharmaceutical industry.
Key Findings of the Report
- In the past decade China has been one of the main
GBI Research, Nov 2010, Pages: 65
. Company shares data for 2009.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within the pharmaceutical analytical services market.
- The report also covers
GBI Research, Jan 2011, Pages: 122
’s Lymphoma (NHL).
Scope
The scope of this report includes:
- Data and analysis on the oncology market in the China
- Annualized market data for the oncology market from 2002 to 2009, with forecasts to 2017
Aruvian's R'search, March 2011, Pages: 145
industry after China, the US and Spain and has shown a steady growth trend. The Canadian pharmaceutical industry is gradually becoming more favorable towards generic drugs rather than branded drugs. Pfizer
Business Insights, Oct 2011, Pages: 112
This report gives an overview of China’s demographics, overall healthcare infrastructure, and the need for healthcare reforms. It provides detailed coverage of China’s healthcare reform plans from
Frost & Sullivan, Dec 2011, Pages: 213
Pharmaceuticals Market in Europe
12. Indian Generic Pharmaceuticals Market
13. Chinese Generic Pharmaceuticals Market
14. The Last Word
15. Summary of Major Findings - Total Market
16. Appendix Generic
Datamonitor, Nov 2010, Pages: 244
China - Industry infrastructure analysis
Publications and online articles
Datamonitor reports and products
Appendix
Exchange rates used in this report
Datamonitor prescription pharmaceutical
Biopharm Knowledge Publishing, Jan 2010, Pages: 150
and pharmacology testing, product, process and analytical development, R&D, and regulatory affairs. It is aimed at biotech, big pharma, CROs, providers of analytical services and regulatory agencies. The report
